or Try an Advanced Search...

    ETF Components for GNOM - Global X Genomics & Biotechnology ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    VCYT B -2.97 4.69
    CRSP D 0.85 4.66
    NTRA B -3.34 4.41
    ARWR D -13.26 4.31
    TECH D -6.85 4.21
    ILMN C -5.05 4.14
    QGEN D -1.95 4.09
    RNA C -15.59 4.06
    BEAM D -8.59 4.03
    A D -2.42 3.93
    BNTX D -3.71 3.83
    BMRN F -3.32 3.71
    ALNY D -8.67 3.71
    RARE F -6.07 3.63
    LEGN F -4.26 3.56
    SRPT F -4.19 3.55
    NTLA F -7.61 3.23
    MRNA F -7.34 3.13
    TXG F -5.52 2.93
    MYGN F -2.74 2.80
    RCKT F -5.67 2.62
    GILD B -4.03 2.17
    CDNA D -1.76 2.13
    VRTX C -3.77 2.09
    VIR C -7.29 1.61
    MRVI F -15.00 1.26
    PACB D -14.02 1.18
    SGMO C -4.65 0.99
    RGNX F -13.55 0.95
    ALLO D -7.72 0.79
    VERV D -10.97 0.74
    FLGT F -2.70 0.73
    SANA F -6.56 0.65
    QURE C -8.07 0.64
    EDIT F -3.97 0.50
    PSTX D -14.02 0.44
    CRBU D -4.78 0.42
    TSVT F -10.20 0.41
    LYEL D 0.00 0.31
    SCLX F -10.31 0.01

    Represented by ETF Holdings

    Keywords: Biotechnology Life Sciences Biology Medicine Biopharmaceutical Cancer Acid Genetics Molecular Biology Clinical Medicine Immune System Disease Gene Therapy In Vitro S&P 500 Applied Genetics Chimeric Antigen Receptor T Cell Gene Expression Genome Genomics
    Industries: Biotechnology Diagnostics & Research Drug Manufacturers - General Drug Manufacturers - Major Health Information Services

    Recent News for Global X Genomics & Biotechnology ETF & its Holdings

    Date Stock Title
    Nov 17 TECH This Week In Appleverse: $3.8B Lawsuit, EU Directives, And Upcoming Products
    Nov 17 TECH Former Uber Executive And 3 Congressmen Contenders For Trump's Transportation Chief Role: Report
    Nov 17 TECH Jake Paul Vs. Mike Tyson Boxing Match Sets 'Record-Breaking Night' For Netflix: Streaming Giant Says Nearly 60M Households Tuned In
    Nov 17 TECH Nikola Recalls 72 Of Its Trouble-Ridden BEV Trucks As Display Failure Raises Crash Risk
    Nov 17 TECH Elon Musk's SpaceX Delays Starship Test Flight, Next Attempt Now Set For Tuesday
    Nov 16 TECH Consumer Tech News (November 11-15): Apple Plans To Launch An AI Wall Tablet, Meta Plans To Introduce Ads On Threads & More
    Nov 16 TECH Sean Parker's Net Worth Touches $3B: From Launching Napster To Becoming Facebook Billionaire, The Story Of Teenage Hacker Turned Entrepreneur
    Nov 16 MRNA What Moved Markets This Week
    Nov 16 CRSP 2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
    Nov 16 TECH OpenAI Co-Founders, Now Rivals Sam Altman And Elon Musk Clash Over ChatGPT And xAI's Grok Chatbots Again
    Nov 16 TECH Cathie Wood Backs Elon Musk's $2 Trillion DOGE Initiative, Says Tesla CEO's Access To 'Proprietary Data' And AI Gives Him An Edge
    Nov 16 TECH IBM, Disney And Other Large Advertisers Return To Elon Musk's X After A Year-Long Boycott: 'We Super Appreciate'
    Nov 16 TECH SpaceX To Launch Tender Offer, Valuing Company At Over $250 Billion: Report
    Nov 16 TECH T-Mobile Hit By Chinese Hackers After Rivals AT&T, Verizon Suffer Breach: Report
    Nov 16 TECH Major Investor In Trump Media Offloads Most Of Its Stake In DJT Stock
    Nov 16 TECH Elon Musk's xAI Seeks $6B At $50B Valuation To Acquire 100K Nvidia Chips For Memphis Data Center
    Nov 15 MRNA Moderna, Inc. (MRNA) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript)
    Nov 15 MRNA How analysts are reacting to RFK Jr. as Trump's HHS pick
    Nov 15 A Life sciences stocks viewed positively at TD Cowen despite post-election weakness
    Nov 15 ILMN Life sciences stocks viewed positively at TD Cowen despite post-election weakness
    The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Biotechnology Genomics
    Back to the Main GNOM Page...